108 related articles for article (PubMed ID: 29211670)
1. Long-Term Effects of G-CSF Therapy in Cyclic Neutropenia.
Dale DC; Bolyard A; Marrero T; Makaryan V; Bonilla M; Link DC; Newburger P; Shimamura A; Boxer LA; Spiekerman C
N Engl J Med; 2017 Dec; 377(23):2290-2292. PubMed ID: 29211670
[No Abstract] [Full Text] [Related]
2. Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia.
Freedman MH
Curr Opin Hematol; 1997 May; 4(3):217-24. PubMed ID: 9209840
[TBL] [Abstract][Full Text] [Related]
3. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
4. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
Castagnola E; Dufour C
Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
[TBL] [Abstract][Full Text] [Related]
5. Neutrophilic dermatoses in two children with idiopathic neutropenia: association with granulocyte colony-stimulating factor (G-CSF) therapy.
Prendiville J; Thiessen P; Mallory SB
Pediatr Dermatol; 2001; 18(5):417-21. PubMed ID: 11737689
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia.
Hung MJ; Wang CH; Cherng WJ
Int J Clin Pract; 2002; 56(1):70-1. PubMed ID: 11831843
[TBL] [Abstract][Full Text] [Related]
7. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
Heussner P; Haase D; Kanz L; Fonatsch C; Welte K; Freund M
Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
[TBL] [Abstract][Full Text] [Related]
8. [Leukemogenic risk during long-term use of G-CSF in constitutional neutropenia].
Donadieu J
Arch Fr Pediatr; 1993 Nov; 50(9):827. PubMed ID: 7520227
[No Abstract] [Full Text] [Related]
9. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
Lehrnbecher T
Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
[TBL] [Abstract][Full Text] [Related]
10. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.
Donadieu J; Leblanc T; Bader Meunier B; Barkaoui M; Fenneteau O; Bertrand Y; Maier-Redelsperger M; Micheau M; Stephan JL; Phillipe N; Bordigoni P; Babin-Boilletot A; Bensaid P; Manel AM; Vilmer E; Thuret I; Blanche S; Gluckman E; Fischer A; Mechinaud F; Joly B; Lamy T; Hermine O; Cassinat B; Bellanné-Chantelot C; Chomienne C;
Haematologica; 2005 Jan; 90(1):45-53. PubMed ID: 15642668
[TBL] [Abstract][Full Text] [Related]
13. Development of Kawasaki syndrome in autoimmune neutropenia after treatment with granulocyte colony-stimulating factor.
Ueno K; Nomura Y; Arata M; Maruyama S; Tanabe T; Eguchi T; Kawano Y
Pediatr Int; 2011 Jun; 53(3):388-90. PubMed ID: 21696506
[No Abstract] [Full Text] [Related]
14. MPGN type I induced by granulocyte colony stimulating factor.
Magen D; Mandel H; Berant M; Ben-Izhak O; Zelikovic I
Pediatr Nephrol; 2002 May; 17(5):370-2. PubMed ID: 12042897
[TBL] [Abstract][Full Text] [Related]
15. G-CSF: a very efficient therapy in chronic autoimmune neutropenia. A brief review of the literature.
Bauduer F
Hematol Cell Ther; 1998 Oct; 40(5):189-91. PubMed ID: 9844813
[TBL] [Abstract][Full Text] [Related]
16. Use of granulocyte colony-stimulating factor for neutropenia after orthotopic liver transplantation: report of two cases.
Atici AE; Bostanci EB; Ozer I; Ulas M; Akdogan M; Akoglu M
Transplant Proc; 2011 Apr; 43(3):909-11. PubMed ID: 21486626
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-induced neutropenia treated with granulocyte colony-stimulating factor during home intravenous infusion therapy.
Lai KK; Kleinjan J; Belliveau P
Clin Infect Dis; 1996 Oct; 23(4):844-5. PubMed ID: 8909866
[No Abstract] [Full Text] [Related]
18. Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.
Tan H; Tomic K; Hurley D; Daniel G; Barron R; Malin J
Curr Med Res Opin; 2011 Jan; 27(1):79-86. PubMed ID: 21091127
[TBL] [Abstract][Full Text] [Related]
19. Malignant myeloid transformation in congenital forms of neutropenia.
Freedman MH; Alter BP
Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib.
Wang WC; Crist WM; Ihle JN; Arnold BA; Keating JP
Leukemia; 1991 Apr; 5(4):347-9. PubMed ID: 1709246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
